TMS is an FDA cleared, noninvasive and nonmedication treatment option that uses electromagnetism to effectively treat depression in patients who have failed prior antidepressant treatments.
Transcranial Magnetic Stimulation (TMS) has been studied for over 30 years, initially as a way of mapping specific areas of the brain to assist researchers in their studies. Soon researchers began to wonder if stimulating the brain in specific areas could be used to treat a variety of different illnesses. After multiple studies, TMS received FDA clearance in 2008 to treat Major Depressive Disorder in patients who had failed one antidepressant trial. Since then, advances in the treatment and technique of TMS have contributed to the growing body of evidence that TMS is a powerful tool for treating depression.
TMS treats depression by transmitting electromagnetic pulses to a particular part of the brain, the dorsolateral prefrontal cortex. Nerves in this part of the brain are stimulated by these pulses and, with repeated treatments over the course of a few weeks, this stimulation results in a significant decrease in depressive symptoms for many patients. Not only is TMS treatment effective, the side effects are minimal and the results are durable for most patients. TMS can be used as a stand-alone treatment for depression or it can be used in concert with medications and therapy.
Jonathan Horey, M.D., is board-certified in adult psychiatry and addiction medicine and is the co-founder and Chief Medical Officer of Active Recovery TMS. Dr. Horey completed medical school and psychiatry residency at Columbia University in New York City where he served as Chief Resident. He became familiar with transcranial magnetic stimulation (TMS) while at Columbia, where many of the early clinical TMS studies were conducted.
After moving to Portland, OR, he was a staff psychiatrist at Betty Ford-Hazelden Springbrook and Chief Medical Officer at Sunspire Health before co-founding Active Recovery TMS to fill a void of TMS treatment in the region.
Dr. Horey has lectured widely on addiction medicine as well as on TMS and is an advanced candidate in psychoanalysis at the Oregon Psychoanalytic Institute.
Dr. Horey was involved with the published research that studied antosocial behavior syndromes in over 240 patients that were drug dependent. This study was published in 2008 in New York City, New York.
Read moreDr. Horey was involved with the published research that studied antosocial behavior syndromes in over 240 patients that were drug dependent. This study was published in 2008 in New York City, New York.
Read more
An FDA approved treatment for those in which antidepressants have not worked. TMS has been FDA approved for the treatment of Major Depressive Disorder in
patients whose symptoms have not improved after one or more trials of
antidepressants.
Other studies have suggested benefit from TMS for a wide range of conditions such
as OCD, anxiety, autism, tinnitus, Parkinson’s disease, PTSD and addictive disorders. However, TMS has not been FDA approved for any condition except Major
Depressive Disorder after adequate antidepressant medication trials.
At Active Recovery TMS, our goal is to provide a safe and effective alternative treatment for depression. Transcranial Magnetic Stimulation (TMS) is an especially important treatment option for those who have not had success with standard depression treatments like medication and/or therapy.
Our co-founder, Dr. Horey, became familiar with TMS while training and working at Columbia University in New York City where many of the early and important studies on TMS were conducted. Dr. Horey has since completed more extensive training in TMS and keeps himself up-to-date with the latest research on brain stimulation techniques, including TMS.
read more